Cholera articles
-
Eubiologics wins WHO prequalification for oral cholera vaccine
South Korea’s Eubiologics Co. Ltd. said it gained the World Health Organization’s (WHO) prequalification designation on April 16 for its simplified oral cholera vaccine, approved as Euvichol-S.
-
WHO prequalifies simplified version of oral cholera vaccine
Two facilities in South Korea are expected to begin producing the vaccine in the second quarter of the year, which is expected to help ease severe vaccine shortages.
-
Demand for the cholera vaccine is soaring – this company might have a solution
South Korea facility bears the international burden of mass producing oral cholera vaccines to stem an acute stockpile shortage